Mesh Enclosed Tissue Constructs for Heart Valve Leaflets
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current heart valve leaflet technologies face challenges in achieving structural stability, long-term functionality, and biocompatibility, with existing scaffolds either being mechanically weak or causing immunogenic reactions due to enzymatic degradation or cytotoxicity.
Innovation Solution
A heart valve leaflet made from a metal mesh, such as Nitinol, coated with bioactive materials to capture and recruit cells, forming a multi-layered biological matrix that encloses the mesh, providing mechanical strength and biocompatibility, and mimicking native heart valve function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If biodegradable naturally-derived or synthetic polymers are used as scaffolds, then the scaffolds can be degraded by normal metabolic activity while biological matrix is formed, but the scaffolds have poor control of enzymatic degradation and low mechanical performance
Solution Approach 1:
The invention uses composite materials combining biodegradable polymers with living cells to create tissue-engineered heart valves. The polymer scaffold provides initial structural support while cells progressively replace it with functional tissue, resolving the contradiction between degradation control and mechanical performance by transitioning from synthetic to biological material over time
Solution Approach 2:
The scaffold is designed to be degraded by normal metabolic activity of the host body, utilizing the body's own enzymatic systems to break down the polymer and replace it with biological matrix. This self-service approach allows controlled degradation without external intervention while maintaining mechanical integrity during the transition period
2Manufacturing precision
If synthetic polymers are used as scaffolds, then the scaffolds can be prepared precisely with respect to structure and function, but they produce toxic chemicals when they degrade in vivo and may not provide a good environment for adhesion and proliferation of cells
Solution Approach 1:
The invention changes the chemical parameters of the scaffold material from synthetic polymers to biodegradable naturally-derived polymers and eventually to completely biological matrix components. This parameter change eliminates toxic degradation products while maintaining manufacturing precision through controlled biological processes
Solution Approach 2:
The scaffold is designed with porous structure that allows cell infiltration, nutrient transport, and waste removal. The porous architecture provides a favorable environment for cell adhesion and proliferation while maintaining structural integrity, resolving the contradiction between manufacturing precision and biocompatibility
3Adaptability or versatility
If decellularized xenogenic tissues are used as scaffolds, then they provide a unique scaffold composed of extracellular matrix proteins that serve as an intrinsic template for cells, but the process of decellularization cannot completely remove the trace of cells and their debris which increase the potential of immunogenic reaction and tissue susceptibility to calcification
Solution Approach 1:
The invention extracts and removes all cellular components from xenogenic tissues through decellularization processes, leaving only the extracellular matrix framework. This extraction eliminates immunogenic cellular debris while preserving the beneficial ECM template structure that guides cell behavior and tissue formation
Solution Approach 2:
The invention converts the potential harm of residual cellular debris causing immunogenic reactions into a benefit by using the decellularized ECM as a pure template. The rigorous decellularization process transforms what would be harmful remnants into a cleaned, immunologically inert framework that actively promotes tissue regeneration
4Quantity of substance
If a scaffold with completely biological matrix components is created, then large amounts can be produced from xenogenic sources which can readily accommodate cellular ingrowth without cytotoxic degradation products, but the scaffold has mechanical fragility and low potentials for creating complex tissue structures
Solution Approach 1:
The invention applies preliminary action by providing a pre-formed synthetic or decellularized scaffold framework before introducing living cells. This preliminary structural support allows cells to populate and differentiate without being constrained by the mechanical limitations of purely biological materials during early development
Solution Approach 2:
The invention uses composite materials combining synthetic polymers or decellularized ECM with living cells to create tissue-engineered constructs. The composite structure leverages the mechanical strength of the synthetic/framework component and the regenerative capabilities of the biological component, resolving the contradiction between quantity of biological material and mechanical strength
Data Source
AI summary
Described is a heart valve leaflet manufactured from a mesh material. The mesh material may have an ability to capture circulatory/stationary/migratory cells of the body to become biologically active. In some cases, the mesh material is coated with a bioactive material, such as a molecule that binds to a cell adhesion molecule (CAM), a growth factor, an extracellular matrix molecule, a subendothelial extracellular matrix molecule or a peptide. The mesh has a stiffness that is comparable to a native heart valve leaflet, such that it functionally mimics a native heart valve.